Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT
Known as:
DKCA1
, DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1
, DYSKERATOSIS CONGENITA, SCOGGINS TYPE
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Alopecia
Anemia
Aplastic Anemia
Atrophic condition of skin
Expand
Broader (1)
Dyskeratosis Congenita
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
2018 Presidential Address—Society of Surgical Oncology: The Fundamental Difference Between Cancer Treatment and Patient Care
K. McMasters
Annals of Surgical Oncology
2018
Corpus ID: 195232404
2015
2015
Long tails, short telomeres: Dyskeratosis congenita
H. Tummala
,
A. Walne
OncoTarget
2015
Corpus ID: 12531777
Dyskeratosis congenita (DC) is an inherited life threatening bone marrow failure syndrome [1]. The name dyskeratosis comes from…
Expand
2015
2015
[Genotype analysis and telomere length measure in patients with dyskeratosis congenita].
Jia-yuan Zhang
,
W. An
,
+7 authors
Xiao-Fan Zhu
Zhongguo shi yan xue ye xue za zhi
2015
Corpus ID: 26125682
OBJECTIVE To analysze genotype and measure telomere length in two Chinese patients with dyskeratosis congenita(DC). METHODS The…
Expand
2015
2015
Genetic condition awaiting consideration - Dyskeratosis Congenita (DKCA1)
Human Fertilisation
,
Information Directorate
,
Web Team
2015
Corpus ID: 57317332
2014
2014
Consistent Upregulation of Oxidative Stress and DNA Damage Amongst Dyskeratosis Congenita Genotypes: Ameliorative Effects of Antioxidants
L. Pereboeva
,
E. Westin
,
Meredith Hubbard
,
F. Goldman
2014
Corpus ID: 91065941
Introduction: Dyskeratosis congenita (DC) is an inherited multisystem disorder characterized by the classical clinical triad of…
Expand
2013
2013
Pharmaceutical composition for preventing or treating dyskeratosis follicularis, containing catechin or derivative thereof
서대헌
2013
Corpus ID: 140394723
The present application provides: a pharmaceutical composition for preventing or treating Dyskeratosis follicularis, containing…
Expand
2012
2012
DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita.
L. Pereboeva
,
E. Westin
,
+4 authors
F. Goldman
2012
Corpus ID: 208444100
Abstract 2359 Introduction: Dyskeratosis congenita (DC) is an inherited multisystem disorder consisting of premature aging…
Expand
2009
2009
Telomere Elongation in Dyskeratosis Congenita Induced Pluripotent Stem Cells.
Suneet Agarwal
,
Y. Loh
,
+12 authors
G. Daley
2009
Corpus ID: 208397963
Abstract 497 Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer premature degeneration of…
Expand
2007
2007
The Impact of Telomere Shortening in Dyskeratosis Congenita Cells on DNA Damage Response Pathways.
T. Witt
,
A. Klingelhutz
,
E. Westin
,
P. Satyanarayana
,
P. Lansdorp
,
F. Goldman
2007
Corpus ID: 88844048
Dyskeratosis congenita (DC) is an inherited multisystem disorder of premature aging, typically characterized by bone marrow…
Expand
Review
2005
Review
2005
Clinical trials in New Zealand--treading water in the knowledge wave?
A. Jull
,
Mary J Wills
,
B. Scoggins
,
A. Rodgers
The New Zealand medical journal
2005
Corpus ID: 44728039
AIMS To describe the number and type of clinical trials in New Zealand 1998-2003, and to identify the number of trials for which…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE